Michael Kelly
Vermögen: 426 944 $ am 31.07.2026
Vermögen: 426 944 $ am 31.07.2026
Mr. Michael Kelly is an Independent Director at ARS Pharmaceuticals, Inc. He is on the Board of Directors at ARS Pharmaceuticals Operations, Inc. and ARS Pharmaceuticals, Inc. Mr. Kelly was previously employed as a President, Chief Executive Officer & Director by NervGen Pharma Corp., a President-US Operations by Adapt Pharma, Inc., a President by Covis Pharmaceuticals, Inc., a Senior Vice President-Sales & Marketing by Jazz Pharmaceuticals Plc, a Senior Vice President & General Manager by Azur Pharma, Inc., a Vice President-Commercial Operations by Guilford Pharmaceuticals, Inc., a Member by Azur Pharma Ltd., and a Vice President-Sales and Marketing by Viropharma, Inc. He received his undergraduate degree from The College of New Jersey and an MBA from Rider University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.06.2026 | 83.225 ( 0,08 % ) | 426 944 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ARS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.05.2019 |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Direktor/Vorstandsmitglied | 01.05.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
| NERVGEN PHARMA CORP. | Vorstandsvorsitzender | 17.07.2025 |
Emergent Devices, Inc.
Emergent Devices, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Geschäftsführer | 01.06.2019 |
Covis Pharmaceuticals, Inc.
Covis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Vorstandsvorsitzender | 01.03.2016 |
Azur Pharma Ltd.
Azur Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 27.01.2012 |
Jazz Pharmaceuticals Commercial Corp.
Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Corporate Officer/Principal | 01.01.2012 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases | Health Technology |
The College of New Jersey
The College of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rider University
Rider University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Azur Pharma Ltd.
Azur Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Jazz Pharmaceuticals Commercial Corp.
Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Health Technology |
Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Covis Pharmaceuticals, Inc.
Covis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
NervGen Pharma Corp.
NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Health Technology |
Emergent Devices, Inc.
Emergent Devices, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Viropharma, Inc. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen